2025
Modeling the Impact of Smoking on Mortality in Argentina From 2000 to 2100. A Maximum Potential Reduction in Premature Mortality Analysis
Salgado M, Cao P, Jeon J, Sanchez-Romero L, Holford T, Levy D, Tam J, Mejia R, Meza R. Modeling the Impact of Smoking on Mortality in Argentina From 2000 to 2100. A Maximum Potential Reduction in Premature Mortality Analysis. Nicotine & Tobacco Research 2025, ntaf117. PMID: 40448284, DOI: 10.1093/ntr/ntaf117.Peer-Reviewed Original ResearchSmoking-attributable deathsTobacco control interventionsSmoking-attributable mortalitySmoking prevalenceControl interventionsLife yearsAdult smoking prevalenceSmoking-related mortalityPremature deathBurden of smokingPotential health gainsReduce smoking ratesPublic health effortsYears of lifeImpact of smokingSmoking trendsPopulation healthSmoking ratesHealth effortsHealth gainsPremature mortalityModel of cigarette smokeMortality burdenBirth cohortStatus quo scenario
2024
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study
van Lieshout Titan A, Klaassen F, Pelissari D, de Barros Silva J, Alves K, Alves L, Sanchez M, Bartholomay P, Johansen F, Croda J, Andrews J, Castro M, Cohen T, Vuik C, Menzies N. Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study. The Lancet Global Health 2024, 12: e1446-e1455. PMID: 39151980, PMCID: PMC11339731, DOI: 10.1016/s2214-109x(24)00221-3.Peer-Reviewed Original ResearchConceptsDisability-adjusted life yearsTuberculosis preventive treatmentTuberculosis deathsHealth impactsImpact of screeningIntervention cost-effectivenessInfection screeningCost-effectiveNational Institutes of HealthHealth outcomesHealth gainsInstitutes of HealthQuantify health effectsTuberculosis casesCost-effectiveness ratioTreatment of Mycobacterium tuberculosis infectionPotential health impactsLife yearsGreater health benefitsTuberculosis preventionTarget populationMonths of isoniazidMarkov modelling studiesHealth statesHealth
2022
Intended and unintended effects of e-cigarette taxes on youth tobacco use
Abouk R, Courtemanche C, Dave D, Feng B, Friedman A, Maclean J, Pesko M, Sabia J, Safford S. Intended and unintended effects of e-cigarette taxes on youth tobacco use. Journal Of Health Economics 2022, 87: 102720. PMID: 36565585, PMCID: PMC9879683, DOI: 10.1016/j.jhealeco.2022.102720.Peer-Reviewed Original Research
2020
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Collaborators G, Lozano R, Fullman N, Mumford J, Knight M, Barthelemy C, Abbafati C, Abbastabar H, Abd-Allah F, Abdollahi M, Abedi A, Abolhassani H, Abosetugn A, Abreu L, Abrigo M, Abu Haimed A, Abushouk A, Adabi M, Adebayo O, Adekanmbi V, Adelson J, Adetokunboh O, Adham D, Advani S, Afshin A, Agarwal G, Agasthi P, Aghamir S, Agrawal A, Ahmad T, Akinyemi R, Alahdab F, Al-Aly Z, Alam K, Albertson S, Alemu Y, Alhassan R, Ali M, Ali S, Alipour V, Aljunid S, Alla F, Almadi M, Almasi A, Almasi-Hashiani A, Almasri N, Al-Mekhlafi H, Almulhim A, Alonso J, Al-Raddadi R, Altirkawi K, Alvis-Guzman N, Alvis-Zakzuk N, Amini S, Amini-Rarani M, Amiri F, Amit A, Amugsi D, Ancuceanu R, Anderlini D, Andrei C, Androudi S, Ansari F, Ansari-Moghaddam A, Antonio C, Antony C, Antriyandarti E, Anvari D, Anwer R, Arabloo J, Arab-Zozani M, Aravkin A, Aremu O, Ärnlöv J, Asaad M, Asadi-Aliabadi M, Asadi-Pooya A, Ashbaugh C, Athari S, Atout M, Ausloos M, Avila-Burgos L, Quintanilla B, Ayano G, Ayanore M, Aynalem Y, Aynalem G, Ayza M, Azari S, Azzopardi P, Darshan B, Babaee E, Badiye A, Bahrami M, Baig A, Bakhshaei M, Bakhtiari A, Bakkannavar S, Balachandran A, Balassyano S, Banach M, Banerjee S, Banik P, Bante A, Bante S, Barker-Collo S, Bärnighausen T, Barrero L, Bassat Q, Basu S, Baune B, Bayati M, Baye B, Bedi N, Beghi E, Behzadifar M, Bekuma T, Bell M, Bensenor I, Berman A, Bernabe E, Bernstein R, Bhagavathula A, Bhandari D, Bhardwaj P, Bhat A, Bhattacharyya K, Bhattarai S, Bhutta Z, Bijani A, Bikbov B, Bilano V, Biondi A, Birihane B, Bockarie M, Bohlouli S, Bojia H, Bolla S, Boloor A, Brady O, Braithwaite D, Briant P, Briggs A, Briko N, Nagaraja S, Busse R, Butt Z, dos Santos F, Cahuana-Hurtado L, Cámera L, Cárdenas R, Carreras G, Carrero J, Carvalho F, Castaldelli-Maia J, Castañeda-Orjuela C, Castelpietra G, Castro F, Catalá-López F, Causey K, Cederroth C, Cercy K, Cerin E, Chandan J, Chang A, Charan J, Chattu V, Chaturvedi S, Chin K, Cho D, Choi J, Christensen H, Chu D, Chung M, Ciobanu L, Cirillo M, Comfort H, Compton K, Cortesi P, Costa V, Cousin E, Dahlawi S, Damiani G, Dandona L, Dandona R, Gela J, Darwesh A, Daryani A, Dash A, Davey G, Dávila-Cervantes C, Davletov K, De Neve J, Denova-Gutiérrez E, Deribe K, Dervenis N, Desai R, Dharmaratne S, Dhungana G, Dianatinasab M, da Silva D, Diaz D, Dippenaar I, Thi H, Dorostkar F, Doshmangir L, Duncan B, Duraes A, Eagan A, Edvardsson D, Sayed I, Tantawi M, Elgendy I, Elyazar I, Eskandari K, Eskandarieh S, Esmaeilnejad S, Esteghamati A, Ezekannagha O, Farag T, Farahmand M, Faraon E, Farinha C, Farioli A, Faris P, Faro A, Fazlzadeh M, Feigin V, Fernandes E, Ferrara P, Feyissa G, Filip I, Fischer F, Fisher J, Flor L, Foigt N, Folayan M, Fomenkov A, Foroutan M, Francis J, Fu W, Fukumoto T, Furtado J, Gad M, Gaidhane A, Gakidou E, Galles N, Gallus S, Gardner W, Geberemariyam B, Gebrehiwot A, Gebremeskel L, Gebremeskel G, Gesesew H, Ghadiri K, Ghafourifard M, Ghashghaee A, Ghith N, Gholamian A, Gilani S, Gill P, Gill T, Ginindza T, Gitimoghaddam M, Giussani G, Glagn M, Gnedovskaya E, Godinho M, Goharinezhad S, Gopalani S, Goudarzian A, Goulart B, Gubari M, Guimarães R, Guled R, Gultie T, Guo Y, Gupta R, Gupta R, Hafezi-Nejad N, Hafiz A, Haile T, Hamadeh R, Hameed S, Hamidi S, Han C, Han H, Handiso D, Hanif A, Hankey G, Haro J, Hasaballah A, Hasan M, Hashi A, Hassan S, Hassan A, Hassanipour S, Hassankhani H, Havmoeller R, Hay S, Hayat K, Heidari G, Heidari-Soureshjani R, Hendrie D, Herteliu C, Hird T, Ho H, Hole M, Holla R, Hollingsworth B, Hoogar P, Hopf K, Horita N, Hossain N, Hosseini M, Hosseinzadeh M, Hostiuc M, Hostiuc S, Househ M, Hsieh V, Hu G, Huda T, Humayun A, Hwang B, Iavicoli I, Ibitoye S, Ikeda N, Ilesanmi O, Ilic I, Ilic M, Inbaraj L, Iqbal U, Irvani S, Irvine C, Islam M, Islam M, Islami F, Iso H, Iwu C, Iwu C, Jaafari J, Jadidi-Niaragh F, Jafarinia M, Jahagirdar D, Jahani M, Jahanmehr N, Jakovljevic M, Janjani H, Javaheri T, Jayatilleke A, Jenabi E, Jha R, Jha V, Ji J, Jia P, John-Akinola Y, Jonas J, Joukar F, Jozwiak J, Jürisson M, Kabir Z, Kalankesh L, Kalhor R, Kamath A, Kanchan T, Kapoor N, Matin B, Karanikolos M, Karimi S, Kassebaum N, Katikireddi S, Kayode G, Keiyoro P, Khader Y, Khammarnia M, Khan M, Khan E, Khang Y, Khatab K, Khater A, Khater M, Khatib M, Khayamzadeh M, Khubchandani J, Kianipour N, Kim Y, Kim Y, Kimokoti R, Kinfu Y, Kisa A, Kissimova-Skarbek K, Kivimäki M, Kneib C, Kocarnik J, Kochhar S, Kohler S, Kopec J, Korotkova A, Korshunov V, Kosen S, Kotlo A, Koul P, Koyanagi A, Krishan K, Krohn K, Kugbey N, Kulkarni V, Kumar G, Kumar N, Kumar M, Kurmi O, Kusuma D, Kyu H, La Vecchia C, Lacey B, Lal D, Lalloo R, Landires I, Lansingh V, Larsson A, Lasrado S, Lau K, Lauriola P, Lazarus J, Ledesma J, Lee P, Lee S, Leever A, LeGrand K, Leigh J, Leonardi M, Li S, Lim S, Lim L, Liu X, Logroscino G, Lopez A, Lopukhov P, Lotufo P, Lu A, Ma J, Madadin M, Mahasha P, Mahmoudi M, Majeed A, Malagón-Rojas J, Maleki S, Malta D, Mansouri B, Mansournia M, Martini S, Martins-Melo F, Martopullo I, Massenburg B, Mastrogiacomo C, Mathur M, McAlinden C, McKee M, Medina-Solís C, Meharie B, Mehndiratta M, Nasab E, Mehri F, Mehrotra R, Mekonnen T, Melese A, Memiah P, Mendoza W, Menezes R, Mensah G, Meretoja T, Meretoja A, Mestrovic T, Miazgowski B, Michalek I, Mirrakhimov E, Mirzaei M, Mirzaei-Alavijeh M, Mitchell P, Moazen B, Moghadaszadeh M, Mohamadi E, Mohammad Y, Mohammad D, Mezerji N, Mohammadian-Hafshejani A, Mohammed S, Mohammed J, Mokdad A, Monasta L, Mondello S, Moradi M, Moradi-Lakeh M, Moradzadeh R, Moraga P, Morgado-da-Costa J, Morrison S, Mosapour A, Mosser J, Khaneghah A, Muriithi M, Mustafa G, Nabhan A, Naderi M, Nagarajan A, Naghavi M, Naghshtabrizi B, Naimzada M, Nangia V, Nansseu J, Nayak V, Nazari J, Ndejjo R, Negoi I, Negoi R, Neupane S, Ngari K, Nguefack-Tsague G, Ngunjiri J, Nguyen C, Nguyen D, Nguyen H, Nnaji C, Nomura S, Norheim O, Noubiap J, Nowak C, Nunez-Samudio V, Otoiu A, Ogbo F, Oghenetega O, Oh I, Okunga E, Oladnabi M, Olagunju A, Olusanya J, Olusanya B, Oluwasanu M, Bali A, Omer M, Ong K, Onwujekwe O, Ortega-Altamirano D, Ortiz A, Ostojic S, Otstavnov N, Otstavnov S, Øverland S, Owolabi M, Padubidri J, Pakhale S, Palladino R, Pana A, Panda-Jonas S, Pangaribuan H, Pathak M, Patton G, Paudel S, Toroudi H, Pease S, Peden A, Pennini A, Peprah E, Pereira J, Pigott D, Pilgrim T, Pilz T, Pinheiro M, Piradov M, Pirsaheb M, Pokhrel K, Postma M, Pourjafar H, Pourmalek F, Kalhori R, Pourshams A, Prada S, Pribadi D, Pupillo E, Syed Z, Radfar A, Rafiee A, Rafiei A, Raggi A, Rahim F, Rahman M, Rajabpour-Sanati A, Rana S, Ranabhat C, Rao S, Rasella D, Rashedi V, Rath G, Rathi P, Rawaf S, Rawaf D, Rawal L, Rawassizadeh R, Razo C, Renjith V, Renzaho A, Reshmi B, Rezaei N, Riahi S, Ribeiro D, Rickard J, Roberts N, Roever L, Romoli M, Ronfani L, Roshandel G, Rubagotti E, Rwegerera G, Sabour S, Sachdev P, Saddik B, Sadeghi M, Sadeghi E, Safari Y, Sagar R, Sahebkar A, Sahraian M, Sajadi S, Salahshoor M, Salem M, Salem H, Salomon J, Kafil H, Samy A, Sanabria J, Santric-Milicevic M, Saraswathy S, Sarmiento-Suárez R, Sartorius B, Sarveazad A, Sathian B, Sathish T, Sattin D, Savic M, Sawyer S, Saxena D, Sbarra A, Schaeffer L, Schiavolin S, Schmidt M, Schutte A, Schwebel D, Schwendicke F, Seedat S, Sha F, Shahabi S, Shaheen A, Shaikh M, Shamsizadeh M, Shannawaz M, Sharafi K, Sharara F, Sharifi H, Shaw D, Sheikh A, Sheikhtaheri A, Shetty B, Shibuya K, Shiferaw W, Shigematsu M, Shin J, Shiri R, Shirkoohi R, Shivakumar K, Shrime M, Shuval K, Siabani S, Sierpinski R, Sigfusdottir I, Sigurvinsdottir R, Silva D, Silva J, Simonetti B, Simpson K, Singh J, Singh P, Sinha D, Skryabin V, Smith E, Soheili A, Soltani S, Soofi M, Sorensen R, Soriano J, Sorrie M, Soyiri I, Spurlock E, Sreeramareddy C, Stanaway J, Steel N, Stein C, Stokes M, Sufiyan M, Suleria H, Sultan I, Szumowski Ł, Tabarés-Seisdedos R, Tabuchi T, Tadakamadla S, Taddele B, Tadesse D, Taherkhani A, Tamiru A, Tanser F, Tareque I, Tarigan I, Teagle W, Tediosi F, Tefera Y, Tela F, Tessema Z, Thakur B, Titova M, Tonelli M, Topor-Madry R, Topouzis F, Tovani-Palone M, Tran B, Travillian R, Troeger C, Car L, Uddin R, Ullah I, Umeokonkwo C, Unnikrishnan B, Upadhyay E, Uthman O, Vacante M, Valdez P, Varughese S, Vasankari T, Vasseghian Y, Venketasubramanian N, Violante F, Vlassov V, Vollset S, Vongpradith A, Vos T, Waheed Y, Walters M, Wamai R, Wang H, Wang Y, Weintraub R, Weiss J, Werdecker A, Westerman R, Wilner L, Woldu G, Wolfe C, Wu A, Hanson S, Xie Y, Xu R, Jabbari S, Yamagishi K, Yano Y, Yaya S, Yazdi-Feyzabadi V, Yearwood J, Yeshitila Y, Yip P, Yonemoto N, Younis M, Yousefi Z, Yousefinezhadi T, Yusefzadeh H, Zadey S, Moghadam T, Zaidi S, Zaki L, Bin Zaman S, Zamani M, Zamanian M, Zandian H, Zastrozhin M, Zewdie K, Zhang Y, Zhao X, Zhao Y, Zheng P, Zhu C, Ziapour A, Zlavog B, Zodpey S, Murray C. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet 2020, 396: 1250-1284. PMID: 32861314, PMCID: PMC7562819, DOI: 10.1016/s0140-6736(20)30750-9.Peer-Reviewed Original ResearchConceptsNon-communicable diseasesUniversal health coveragePotential health gainsHealth servicesCoverage indicatorsHealth gainsGlobal burdenHealth profilePopulation age groupsHealth needsRisk Factors Study (GBD) 2019Non-communicable disease burdenHealth spendingUHC service coverage indexHealth service typeDisease Study 2019Health coverageService coverage indexHealth system levelImproved health outcomesCountry's health profileCoverage indexPopulation health needsIncidence ratiosGBD 2017
2017
Reductions in Readmission Rates Are Associated With Modest Improvements in Patient-reported Health Gains Following Hip and Knee Replacement in England
Friebel R, Dharmarajan K, Krumholz HM, Steventon A. Reductions in Readmission Rates Are Associated With Modest Improvements in Patient-reported Health Gains Following Hip and Knee Replacement in England. Medical Care 2017, 55: 834-840. PMID: 28742545, PMCID: PMC5555974, DOI: 10.1097/mlr.0000000000000779.Peer-Reviewed Original ResearchConceptsRisk-adjusted readmission ratesReadmission ratesEQ-VASHealth gainsEQ-5DKnee replacementHip replacementOxford Hip ScoreOxford Knee ScorePatient-reported healthPatient-reported outcomesVisual analog scaleKnee replacement surgeryReadmission reduction initiativesHealth care systemAdditional health gainsHip scoreKnee scoreAnalog scalePresurgical assessmentReplacement surgeryPatients' senseHospital groupModest ImprovementPatient health
2016
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models
Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, Cohen T, Denholm JT, Dowdy DW, Eckhoff PA, Goldhaber-Fiebert JD, Handel A, Huynh GH, Lalli M, Lin HH, Mandal S, McBryde ES, Pandey S, Salomon JA, Suen SC, Sumner T, Trauer JM, Wagner BG, Whalen CC, Wu CY, Boccia D, Chadha VK, Charalambous S, Chin DP, Churchyard G, Daniels C, Dewan P, Ditiu L, Eaton JW, Grant AD, Hippner P, Hosseini M, Mametja D, Pretorius C, Pillay Y, Rade K, Sahu S, Wang L, Houben RMGJ, Kimerling ME, White RG, Vassall A. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. The Lancet Global Health 2016, 4: e816-e826. PMID: 27720689, PMCID: PMC5527122, DOI: 10.1016/s2214-109x(16)30265-0.Peer-Reviewed Original ResearchMeSH KeywordsChinaCost-Benefit AnalysisDelivery of Health CareForecastingGoalsHealth Care CostsHealth ExpendituresHealth PolicyHealth ResourcesHealth Services AccessibilityHealth Services Needs and DemandHumansIndiaModels, TheoreticalPatient Acceptance of Health CareQuality-Adjusted Life YearsSouth AfricaTuberculosisConceptsPatient-incurred costsTuberculosis servicesConventional cost-effectiveness thresholdsHigh-burden countriesEnd TB StrategySubstantial health gainsNet cost savingsResource implicationsCost-effectiveness thresholdMost intervention approachesTB StrategyTuberculosis incidenceMost interventionsSocietal perspectiveHealth gainsIntervention mixMelinda Gates FoundationSubstantial healthHealth effectsCurrent practiceExpansion of accessIntervention approachesEmpirical cost dataCost dataIntervention
2015
Comparative Assessment of Different Health Utility Measures in Systemic Lupus Erythematosus
Wang SL, Hsieh E, Zhu LA, Wu B, Lu LJ. Comparative Assessment of Different Health Utility Measures in Systemic Lupus Erythematosus. Scientific Reports 2015, 5: 13297. PMID: 26293686, PMCID: PMC4543990, DOI: 10.1038/srep13297.Peer-Reviewed Original ResearchConceptsVisual analog scaleSLEDAI scoreSLE patientsEQ-5DSystemic lupus erythematosus populationSystemic lupus erythematosusStandard gamblePromising outcome measureGood intraclass correlationHealth utility measuresQuality of lifeLupusQoL domainsLupus erythematosusAnalog scaleOutcome measuresBest predictorHealth interventionsHealth systemHealth gainsUtility instrumentsEmotional healthPatientsIntraclass correlationUtility valuesTherapeutic boundariesHeavy-Drinking Smokers' Treatment Needs and Preferences: A Mixed-Methods Study
Fucito LM, Hanrahan TH. Heavy-Drinking Smokers' Treatment Needs and Preferences: A Mixed-Methods Study. Journal Of Substance Use And Addiction Treatment 2015, 59: 38-44. PMID: 26297324, PMCID: PMC4548819, DOI: 10.1016/j.jsat.2015.07.001.Peer-Reviewed Original ResearchConceptsAlcohol interventionsHeavy drinking smokersMixed-methods studyPerceptions of smokingSmoking cessationTreatment preferencesSmokingStress/negative affectHealth gainsHealth feedbackTreatment formatStrong associationSemi-structured focus group interviewsTreatment modelSmokersOverall enthusiasmDrinkingBehavior changeInterventionGreatest barrierMethods studyTreatmentStandardized surveyFocus group interviewsParticipants
2011
Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries
Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, Thorien K, Hecht R, Atun R. Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries. PLOS ONE 2011, 6: e25310. PMID: 21998648, PMCID: PMC3187775, DOI: 10.1371/journal.pone.0025310.Peer-Reviewed Original ResearchConceptsMiddle-income countriesAIDS treatmentProgram costsIncome countriesLarge health gainsAntiretroviral therapyHIV infectionOpportunistic infectionsGlobal FundLife careMedical treatmentAIDS diseaseTreatment programHealth gainsCurrent cohortTotal program costsTreatmentPatientsCohortInfectionCareEnd 2011Same periodEconomic benefitsLabor productivity effects
2000
Cost-Effective Use of Nevirapine to Prevent Vertical HIV Transmission in Sub-Saharan Africa
Stringer J, Rouse D, Vermund S, Goldenberg R, Sinkala M, Stinnett A. Cost-Effective Use of Nevirapine to Prevent Vertical HIV Transmission in Sub-Saharan Africa. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 24: 369-377. DOI: 10.1097/00126334-200008010-00010.Peer-Reviewed Original ResearchVertical HIV transmissionHIV transmissionPrenatal carePrevention strategiesEffects of NVPModest clinical efficacyOptimal prevention strategiesGreater health gainsDecision analysis modelNevirapine administrationNVP administrationPrenatal visitPreventive therapyStandard therapyClinical efficacySaharan AfricaMass therapyPrenatal strategiesClinical assessmentPrior enrollmentTherapyCost-effective useHealth gainsWomenSerostatusCost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa.
Stringer J, Rouse D, Vermund S, Goldenberg R, Sinkala M, Stinnett A. Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 24: 369-77. PMID: 11015154, DOI: 10.1097/00126334-200008010-00012.Peer-Reviewed Original ResearchConceptsVertical HIV transmissionHIV transmissionPrenatal carePrevention strategiesEffects of NVPModest clinical efficacyOptimal prevention strategiesSaharan AfricaGreater health gainsDecision analysis modelNevirapine administrationNVP administrationPrenatal visitPreventive therapyStandard therapyClinical efficacyMass therapyPrenatal strategiesClinical assessmentPrior enrollmentTherapyCost-effective useHealth gainsWomenSerostatusCost-Effective Use of Nevirapine to Prevent Vertical HIV Transmission in Sub-Saharan Africa
Stringer J, Rouse D, Vermund S, Goldenberg R, Sinkala M, Stinnett A. Cost-Effective Use of Nevirapine to Prevent Vertical HIV Transmission in Sub-Saharan Africa. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 24: 369-377. DOI: 10.1097/00042560-200008010-00012.Peer-Reviewed Original ResearchConceptsVertical HIV transmissionHIV transmissionPrenatal carePrevention strategiesEffects of NVPModest clinical efficacyOptimal prevention strategiesGreater health gainsDecision analysis modelNevirapine administrationNVP administrationPrenatal visitPreventive therapyStandard therapyClinical efficacySaharan AfricaMass therapyPrenatal strategiesClinical assessmentPrior enrollmentTherapyCost-effective useHealth gainsWomenSerostatusAging successfully: the importance of physical activity in maintaining health and function.
Galloway M, Jokl P. Aging successfully: the importance of physical activity in maintaining health and function. Journal Of The American Academy Of Orthopaedic Surgeons 2000, 8: 37-44. PMID: 10666651, DOI: 10.5435/00124635-200001000-00004.Peer-Reviewed Original ResearchConceptsPhysical activityMusculoskeletal injuriesRegular physical activityAge-related functional declineMajor muscle groupsSignificant health benefitsOlder patientsPrompt recognitionAge-related declineRegular exerciseExercise regimenResistance exerciseAerobic exerciseSeventh decadeFunctional declineHealthy individualsMuscle groupsConditioning exerciseMusculoskeletal functionCompetitive athleticsOlder individualsHealth gainsMajor causeMaster athletesRegular participation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply